Floatz logo

THIOGUANINE ANHYDROUS

Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies

Grupo Argentino de Tratamiento de la Leucemia AgudaSmall moleculePhase 3Dormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
89/ 100

Competitive context

3 Active assets in the Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies cohort.

Asset / SponsorPhaseRating
Cytosin-Arabinosid
Children's Oncology Group
Phase 3BBB
ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)
Joanna Yi
Phase 3BBB
Daunorubicin
Princess Maxima Center for Pediatric Oncology
Phase 3BBB
ASPARAGINASE
Children's Oncology Group
Phase 3BB
PEGASPARGASE
Children's Oncology Group
Phase 3BB

View all 9 →

Same molecule, other indications

THIOGUANINE ANHYDROUS is also rated in:

B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
73 / 100
View asset →
acute lymphoblastic leukemiaDormant
BBB
Indicative ·
72 / 100
View asset →
lymphoblastic lymphomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →